Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 6 June 2025 to Question 55942 on Drugs, what steps his Department is taking to source medications from other manufacturers; and for what reason there has been a shortage of Trandolapril since 2024.

Trandolapril is supplied by two suppliers in the United Kingdom who are both currently experiencing manufacturing issues. The Department issued comprehensive management plans, including advice on alternative medicines, on 17 September 2024 to the National Health Service, general practitioners, and community pharmacies. This included advice on alternatives, and how to manage affected patients. Resupply of this medicine is expected on 3 October 2025.

The Department and NHS England work closely with all relevant manufacturers to resolve supply issues when they arise through a range of actions. This includes expediting future deliveries, diverting stock from other countries, and requesting that suppliers increase manufacturing capacity in the short and longer term to prevent and mitigate the impact on patients as much as possible.